Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignancies-Reference-Cited by-同舟云学术

Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignancies

Published:2012-02-15 Issue:6 Volume:69 Page:1657-1667
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Bose Prithviraj,Perkins Edward B.,Honeycut Connie,Wellons Martha D.,Stefan Tammy,Jacobberger James W.,Kontopodis Emmanouil,Beumer Jan H.,Egorin Merrill J.,Imamura Chiyo K.,Douglas Figg W.,Karp Judith E.,Koc Omer N.,Cooper Brenda W.,Luger Selina M.,Colevas A. Dimitrios,Roberts John D.,Grant Steven

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-012-1839-5.pdf

Reference45 articles.

1. Deininger MWN, Goldman JM, Melo JV (2000) The molecular biology of chronic myeloid leukemia. Blood 96:3343–3356

2. O’Brien SG, Guilhot F, Larson RA et al (2003) Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 348:994–1004

3. Fielding AK (2010) How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 116:3409–3417

4. Clarke MF (2004) Chronic myelogenous leukemia—identifying the Hydra’s heads. N Engl J Med 351:634–636

5. Schiffer CA (2007) BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia. N Engl J Med 357:258–265

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors Influencing the Steady-State Plasma Concentration of Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors and Chronic Myeloid Leukemia;Frontiers in Pharmacology;2020-11-25

2. Symptomatic Biliary Disorders During Lenvatinib Treatment for Thyroid Cancer: An Underestimated Problem;Thyroid;2020-02-01

3. A kinase-independent role for CDK8 in BCR-ABL1+ leukemia;Nature Communications;2019-10-18

4. Nutraceuticals for the Prevention and Cure of Cancer;Nutraceuticals in Veterinary Medicine;2019

5. Regulation of cell signaling pathways by dietary agents for cancer prevention and treatment;Seminars in Cancer Biology;2017-10